Press release distribution to media in EMEA
  • Middle East
  • North Africa
  • Global
  • Business
  • Finance
  • Technology
  • Press
  • About Us
    • Press Release Distribution Services
    • Submit Press Release
    • Contact Us
Submit PR
No Result
View All Result
MENA NEWS | Press release distribution to media in UAE and MENA regions
  • Middle East
  • North Africa
  • Global
  • Business
  • Finance
  • Technology
  • Press
  • About Us
    • Press Release Distribution Services
    • Submit Press Release
    • Contact Us
Submit PR
No Result
View All Result
PR distribution to media in EMEA
Submit PR
Home Press

Cardiac Marker Testing Market worth $5.5 billion by 2025

admin by admin
January 14, 2022
in Press
Cardiac Marker Testing Market worth $5.5 billion by 2025
Share on FacebookShare on Twitter


 


(EMAILWIRE.COM, January 13, 2022 ) According to the new market research report “Cardiac Marker Testing Market by Product (Reagent, Instrument), Component (Troponin I & T, CK-MB, Myoglobin, BNP, hsCRP), Disease (Myocardial Infarction, Congestive Heart Failure, Atheresclerosis), Enduser (Lab, PoC, Academia) – Global Forecasts to 2025″, published by MarketsandMarkets™, the market is estimated to be USD 3.6 billion in 2020 and projected to reach USD 5.5 billion by 2025, at a CAGR of 8.9%.

Browse in-depth TOC on “Cardiac Marker Testing Market”

102 – Tables

37 – Figures

167 – Pages

Download PDF Brochure: –https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=64885447

The growing incidence of cardiovascular diseases, rapidly increasing geriatric population, growing funding from public and private organizations for research on cardiac biomarkers, and ongoing clinical trials for the identification of novel cardiac biomarkers. However, factors such as technical problems related to sample collection and storage and issues related to regulatory and reimbursement systems are expected to restrain market growth to a certain extent.

The cardiac marker testing market includes major Tier I and II suppliers like Roche Diagnostics Ltd. (Switzerland), Abbott Laboratories (US), Siemens Healthineers AG (Germany), and Danaher Corporation (US). These suppliers have their manufacturing facilities spread across regions such as North America and Europe. COVID-19 has impacted their businesses as well.

The cardiac marker testing market is also faced a period of short-term negative growth, which can be attributed to factors such as a greater than 50% drop in the number of patients with cardiovascular conditions and those diagnosed with myocardial infarction. All areas of cardiology service provision sustained significant reductions, which included outpatient clinics, investigations, procedures, and cardiology community services such as cardiac rehabilitation.

Wide use of reagents and kits in all basic diagnostic activities in laboratories, academic institutes, and POC settings is expected to result in the segment occupying the majority of the cardiac marker testing market share

Growing number of cardiac marker testing procedures, accessibility to a wide range of cardiac biomarker reagents and kits, and the growing demand for reliable, specific, and faster detection of cardiovascular diseases at an early stage are the key growth factors for this segment.

Troponin I and T estimated to be the fastest-growing market

Troponin I and T is estimated to be the fastest-growing segment in the cardiac marker testing market. The large share of this segment can be attributed high sensitivity and specificity, long elevation times, and rapid prediction of outcome or mortality.

North America is estimated to be the largest market due increasing incidence of cardiovascular diseases, growing public and private investments, NIH support for the development of novel cardiac biomarkers, and the rising geriatric population.

Request Sample Pages: –https://www.marketsandmarkets.com/requestsampleNew.asp?id=64885447

Asia Pacific likely to emerge as the largest cardiac marker testing market, globally

Asia Pacific is estimated to be the fastest-growing market for cardiac marker testing during the forecast period. The Asia Pacific market is driven due increased healthcare spending by a larger population base, healthcare infrastructure modernization, and the rising penetration of cutting-edge clinical laboratory technologies (especially in rural areas) in Asia Pacific countries.

Roche Diagnostics Ltd. (Switzerland), Abbott Laboratories (US), Siemens Healthineers AG (Germany), and Danaher Corporation (US) are the key players in the global cardiac marker testing market.

Browse Related Reports:

In-Vitro Diagnostics Market by Product & Service (Instrument, Kits), Technology (Immunoassay, MDx, Hematology, Urinalysis), Application (Diabetes, Oncology, Cardiology, Nephrology, Infectious Diseases) End User (Hospitals) – Global Forecast to 2025

https://www.marketsandmarkets.com/Market-Reports/ivd-in-vitro-diagnostics-market-703.html



Source link

Previous Post

Liquid Biopsy in Breast Cancer Market Worth $411.1 Million

Next Post

ECMO Machine Market Worth 305.3 Million USD

RelatedPosts

Press

Manufacturing Operations Management Software Market Projected to Reach CAGR of 6.97% by 2032

(EMAILWIRE.COM, June 17, 2025 ) The Manufacturing Operations Management (MOM) Software Market is becoming a vital component of...

by admin
June 17, 2025
Press

Nfc Chips Market Growth Rate is expected to be around 14.62% during the forecast period 2025 to 2034

(EMAILWIRE.COM, June 17, 2025 ) The global NFC chips market is experiencing substantial growth, fueled by increasing demand...

by admin
June 17, 2025
Press

Corporate Wellness Market Predicted to Reach USD 100 Billion by 2035, Advancing at a CAGR of 4.11%

(EMAILWIRE.COM, June 17, 2025 ) Corporate Wellness Market Overview:The corporate wellness market is experiencing significant growth as organizations...

by admin
June 17, 2025
Press

Bearing Market forecast shows robust CAGR of 8.5% with valuation expected at USD 3,82,680.2 million by 2032

(EMAILWIRE.COM, June 17, 2025 ) Bearing Industry OverviewAccording to a comprehensive research report by Market Research Future (MRFR),...

by admin
June 17, 2025
Load More

Advertize

Latest Post

تدخل GOMUNOINAKI CO., LTD. اليابانية أسواق الشرق الأوسط وأفريقيا بعلامة “feminak” وتشارك في Africa Health ExCon 2025

تدخل GOMUNOINAKI CO., LTD. اليابانية أسواق الشرق الأوسط وأفريقيا بعلامة “feminak” وتشارك في Africa Health ExCon 2025

by admin
June 20, 2025

HONGQI تستعرض الفخامة الشرقية في معرض هونغ كونغ الدولي للسيارات وسلسلة التوريد 2025

HONGQI تستعرض الفخامة الشرقية في معرض هونغ كونغ الدولي للسيارات وسلسلة التوريد 2025

by admin
June 19, 2025

Lemnisk’s Enterprise Strategy Focuses on Doubling  Revenue in Two Quarters

Lemnisk Unveils Industry-First Innovations for the AI Era of Customer Engagement

by admin
June 18, 2025

Four Investment Ideas to Grow Your Wealth in UAE

Maternity Coverage in Health Insurance

by admin
June 18, 2025

Data Center Market to Surpass USD 150 Billion by 2032 | CAGR 7.82% (2024-2032) | Empowering Digital Growth

by admin
June 17, 2025

Medical Tourism Market Set to Surge Beyond USD 150 Billion by 2035 | MRFR Insights

by admin
June 17, 2025

MENANEWS provides press release distribution services for businesses, organizations and other entities with the need to reach media outlets in Europe, Middle east and Africa (MENANEWS) Submit press release or contact us today.

Share Us

CATEGORIES

MIDDLE EAST
NORTH AFRICA
GLOBAL
BUSINESS
FINANCE
TECHNOLOGY
PRESS

Subscribe To Our Newslatter

    © 2025 Copyright MENANEWS.CLUB
    No Result
    View All Result
    • Middle East
    • North Africa
    • Global
    • Business
    • Finance
    • Technology
    • Press
    • About Us
      • Press Release Distribution Services
      • Submit Press Release
      • Contact Us

    © Copyright MenaNews.club™